Evidence map›Paper›PMID 21843636›Full record

ArticleCellular signalling2011

Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.

Michael G Borland, Combiz Khozoie, Prajakta P Albrecht, Bokai Zhu, Christina Lee, Tejas S Lahoti, Frank J Gonzalez, Jeffrey M Peters

Abstract read
In one paragraph

Article in Cellular signalling, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis.Toxicological sciences : an official journal of the Society of Toxicology · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Michael G BorlandDepartment of Veterinary and Biomedical Sciences, The Center of Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, PA 16802, USA.
Combiz Khozoie
Prajakta P Albrecht
Bokai Zhu
Christina Lee
Tejas S Lahoti
Frank J Gonzalez
Jeffrey M Peters
Pennsylvania State University · USNational Cancer Institute · US

Funding

Xenobiotic receptorsZIABC005562 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK J · 2009 to 2025
$26.9M
Xenobiotic ReceptorsZIABC005708 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK J · 2009 to 2025
$16.4M
Modulation of skin cancer by PPARBeta/deltaR01CA124533 · NCI · PENNSYLVANIA STATE UNIVERSITY, THE · PI PETERS, JEFFREY M · 2007 to 2017
$2.4M
Modulation of liver cancer by PPARbeta/deltaR01CA140369 · NCI · PENNSYLVANIA STATE UNIVERSITY, THE · PI PETERS, JEFFREY M · 2010 to 2014
$1.4M
Transcriptional regulation of polycyclic aromatic hydrocarbon metabolismR01CA141029 · NCI · PENNSYLVANIA STATE UNIVERSITY, THE · PI PETERS, JEFFREY M · 2010 to 2013
$1.1M
Modulation of AhR-dependent signaling by PPARb/dR01CA126826 · NCI · PENNSYLVANIA STATE UNIVERSITY, THE · PI PETERS, JEFFREY M · 2009 to 2010
$594k
Liver-Enriched Transcription FactorsZIABC005561 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GONZALEZ, FRANK J · 2009 to 2010
$500k
Intramural NIH HHS ZIA BC005561Intramural NIH HHS ZIA BC005562Intramural NIH HHS ZIA BC005708NCI NIH HHS CA124533NCI NIH HHS CA126826NCI NIH HHS CA140369NCI NIH HHS CA141029NCI NIH HHS R01 CA124533NCI NIH HHS R01 CA126826NCI NIH HHS R01 CA140369NCI NIH HHS R01 CA141029
6 · The paper itself

Abstract

Peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) function and receptor cross-talk with other nuclear receptors, including PPARγ and retinoic acid receptors (RARs), was examined using stable human HaCaT keratinocyte cell lines over-expressing PPARβ/δ or PPARγ. Enhanced ligand-induced expression of two known PPAR target genes, adipocyte differentiation-related protein (ADRP) and angiopoietin-like protein 4 (ANGPTL4), was found in HaCaT keratinocytes over-expressing PPARβ/δ or PPARγ. Over-expression of PPARβ/δ did not modulate the effect of a PPARγ agonist on up-regulation of ADRP or ANGPTL4 mRNA in HaCaT keratinocytes. All-trans retinoic acid (atRA) increased expression of a known RAR target gene, yet despite a high ratio of fatty acid binding protein 5 (FABP5) to cellular retinoic acid binding protein II, did not increase expression of ANGPTL4 or 3-phosphoinositide-dependent-protein kinase 1 (PDPK1), even in HaCaT keratinocytes expressing markedly higher levels of PPARβ/δ. While PPARβ/δ-dependent attenuation of staurosporine- or UVB-induced poly (ADP-ribose) polymerase (PARP) cleavage was not observed, PPARβ/δ- and PPARγ-dependent repression of UVB-induced expression and secretion of inflammatory cytokines was found in HaCaT keratinocytes over-expressing PPARβ/δ or PPARγ. These studies suggest that FABP5 does not transport atRA or GW0742 to PPARβ/δ and promote anti-apoptotic activity by increasing expression of PDPK1, or that PPARβ/δ interferes with PPARγ transcriptional activity. However, these studies demonstrate that stable over-expression of PPARβ/δ or PPARγ significantly increases the efficacy of ligand activation and represses UVB-induced expression of tumor necrosis factor α (TNFα), interleukin 6 (IL6), or IL8 in HaCaT keratinocytes, thereby establishing an excellent model to study the functional role of these receptors in human keratinocytes.

Indexed as

3-Phosphoinositide-Dependent Protein KinasesAngiopoietin-Like Protein 4AngiopoietinsApoptosisCell CycleCell LineCell ProliferationCytochrome P-450 Enzyme SystemFatty Acid-Binding ProteinsGenetic VectorsHumansKeratinocytesMembrane ProteinsPerilipin-2Poly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerases3-Phosphoinositide-Dependent Protein KinasesAngiopoietin-Like Protein 4AngiopoietinsANGPTL4 protein, humanCytochrome P-450 Enzyme SystemFABP5 protein, humanFatty Acid-Binding ProteinsMembrane ProteinsPARP1 protein, humanPDPK1 protein, humanPerilipin-2PLIN2 protein, humanPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesPPAR-betaPPAR deltaPPAR gammaProtein Serine-Threonine KinasesReceptors, Retinoic AcidRecombinant ProteinsRetinoic Acid 4-Hydroxylaseretinoic acid binding protein II, cellularRetinoid X Receptor alphaTretinoin

Identifiers

PMID21843636
PMCPMC3184348
OpenAlexW2141727424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.